logo
One person missing after Glacier collapse buries parts of Swiss village under mud and rock

One person missing after Glacier collapse buries parts of Swiss village under mud and rock

Independent29-05-2025
One person is missing after a huge chunk of a glacier in the Swiss Alps broke off, causing a deluge of ice, mud and rock to bury part of the mountain village of Blatten on Wednesday.
Authorities had been monitoring the slopes above Blatten since ordering residents to leave their homes earlier this month as a precautionary measure due to the risk of a rockslide.
Social media footage captured the rumbling mudslide as it cascaded down the southern Lötschental valley. Images from the scene showed several cabins partially submerged in the debris.
In recent days, authorities had ordered the evacuation of approximately 300 residents and all livestock from the village. This action was prompted by concerns that a 1.5 million cubic meter glacier situated above Blatten was in danger of collapsing.
Local authorities were being deployed by helicopter and across the area to assess the damage and whether there had been any casualties, Jonas Jeitziner, a spokesperson for the Lötschental crisis centre, said.
"An unbelievable amount of material thundered down into the valley," said Matthias Ebener, a spokesperson for local authorities in the southwestern canton of Valais.
One person was missing, Ebener said.
Buildings and infrastructure in the village nestled in the Loetschental valley in southern Switzerland were hit hard by the rockslide.
Swiss President Karin Keller-Sutter expressed her solidarity with the local population as emergency services warned people that the area was hazardous and urged them to stay away, closing off the main road into the valley.
"It's terrible to lose your home," Keller-Sutter said on X.
In 2023, residents of the village of Brienz, in eastern Switzerland, were evacuated before a huge mass of rock slid down a mountainside, stopping just short of the settlement. Brienz was evacuated again last year because of the threat of a further rockslide.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Roche to investigate whether new drug can delay or prevent Alzheimer's disease
Roche to investigate whether new drug can delay or prevent Alzheimer's disease

Reuters

time2 days ago

  • Reuters

Roche to investigate whether new drug can delay or prevent Alzheimer's disease

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

Reuters

time2 days ago

  • Reuters

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.

I'm losing weight but it's nothing to do with Mounjaro – my FREE hack requires zero effort and is so simple
I'm losing weight but it's nothing to do with Mounjaro – my FREE hack requires zero effort and is so simple

The Sun

time3 days ago

  • The Sun

I'm losing weight but it's nothing to do with Mounjaro – my FREE hack requires zero effort and is so simple

A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this year, weight loss jab Mounjaro has helped thousands of Brits shed unwanted weight. 2 2 And whilst many are overjoyed with the results, some have reported major side effects, including burning skin and kidney problems. Not everyone can get the drug prescribed on the NHS either, so for those looking for an alternative, Cristina Gheiceanu, revealed her little known hack. The blonde beauty, from Switzerland revealed that she has used Chat GPT to help her shed 7kg. Taking to Instagram to explain how she did it, Cristina revealed that she first asked the AI chatbot to help her work out a calorie deficit. However, she said that what helped her the most was using the app to track her daily calorie intake. "Instead of using complicated apps, I just sent a voice message to ChatGPT each morning: what I ate, how many calories I wanted to eat that day — and it did all the work." She explained that, in the beginning, she had to tell the bot how much protein and fibre was in her foods, and how many calories they were. However, once she'd added a food once, it remembered how many calories were in it, meaning it became much quicker to track. "I kept using the same chat, so it became faster and easier every day", she said. Cristina said the best thing about her free hack, is that the chatbot puts everything into a table, so that she can track whether she is missing anything. I lost 4st & reversed my age by 10 years but my secret is NOT Mounjaro - here's my tips to feeling amazing in a bikini "If I am missing something, I just send a photo of my fridge and get suggestions", she said. Cristina's (@cristinagheiceanu) video has likely left many people impressed, as it has racked up over 2.7 million views on the social media platform. Instagram users raced to the video's comments section to share their thoughts on the clever hack. One person said: "Thank you so much for sharing this generously with us. WHO IS ELIGIBLE FOR WEIGHT LOSS JABS ON THE NHS? NHS eligibility for weight loss injections has expanded but still lags behind the number who could potentially benefit from taking them. Wegovy, medical name semaglutide, is only available for weight loss through specialist weight management clinics. Patients are typically expected to have tried other weight loss methods before getting a prescription. They may be eligible if their body mass index (BMI) is higher than 30, or higher than 27 if they have a weight-related health condition such as high blood pressure. Mounjaro, known as tirzepatide, is also available from GP practices but currently only to patients with a BMI of 40 or higher (or 37.5 if from a minority ethnic background) plus four weight-related health conditions. The medicines are currently being rationed to the patients most in need. NHS watchdog NICE estimates that more than three million Brits will ultimately be eligible. The GLP-1 injections are prescribed separately by GPs for people with type 2 diabetes, and patients should discuss this with their doctor. "You look stunning!" A second person said: "I tried using your method and it worked really well! Thank you so much for sharing it. "I used to get stuck and overwhelmed trying to calculate and research detailed nutrition info, it was really hard and confusing. "But tracking food using ChatGPT the way you showed is so much easier, more convenient, and way less stressful." A third added: "I did the same thing. It essentially helped cut out the cost of a nutritionist and helped me lose 20 pounds in a healthy, achievable and maintainable way."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store